FOS |
MCF10A (breast epithelial cells) |
(To replace TAM_1uM_36hr) 36 h with 1 uM 4-hydroxytamoxifen (Myers) |
Permissive
Robust
|
Homo sapiens |
ENCSR000DON
|
MA0476.1
|
FOS |
MCF10A (breast epithelial cells) |
4 hours with 1 uM 4-hydroxytamoxifen dissolved in ethanol (Struhl) |
Permissive
Robust
|
Homo sapiens |
ENCSR000DOO
|
MA0476.1
|
FOS |
MCF10A (breast epithelial cells) |
12 hours with 1 uM 4-hydroxytamoxifen dissolved in ethanol (Struhl) |
Permissive
Robust
|
Homo sapiens |
ENCSR000DOP
|
MA0476.1
|
FOS |
MCF10A (breast epithelial cells) |
36 h with 0.01% Ethanol |
Permissive
Robust
|
Homo sapiens |
ENCSR000DOT
|
MA0476.1
|
FOS |
K562 (myelogenous leukemia) |
24 hours following induction with TPA |
Permissive
Robust
|
Homo sapiens |
GSE24777
...
|
MA0099.3
...
|
FOS |
MCF7 (Invasive ductal breast carcinoma) |
E2 |
Permissive
Robust
|
Homo sapiens |
GSE26831
...
|
MA0099.3
...
|
FOS |
BMDM (bone marrow-derived macrophages) |
vehicle 6h |
Permissive
Robust
|
Mus musculus |
GSE72964
...
|
MA0099.3
...
|
FOS |
BMDM (bone marrow-derived macrophages) |
tissuehomogenate 6h |
Permissive
Robust
|
Mus musculus |
GSE72964
...
|
MA0099.3
...
|
FOS |
BMDM (bone marrow-derived macrophages) |
no treatment |
Permissive
Robust
|
Mus musculus |
GSE72964
...
|
MA0099.3
...
|
FOS |
BMDM (bone marrow-derived macrophages) |
KLA 6h |
Permissive
Robust
|
Mus musculus |
GSE72964
...
|
MA0099.3
...
|
FOS |
Flk1+ hemangioblasts |
0d |
Permissive
Robust
|
Mus musculus |
GSE79320
...
|
MA0099.3
...
|
FOS |
cortical neurons |
KCl stimulated |
Permissive
Robust
|
Mus musculus |
GSE60192
...
|
MA0099.3
...
|
FOS |
cortical neurons |
KCl stimulated |
Permissive
Robust
|
Mus musculus |
GSE60192
...
|
MA0099.3
...
|
FOS |
cortical neurons |
KCl stimulated |
Permissive
Robust
|
Mus musculus |
GSE60192
...
|
MA0099.3
...
|
FOS |
cortical neurons |
KCl stimulated |
Permissive
Robust
|
Mus musculus |
GSE60192
...
|
MA0099.3
...
|
FOS |
cortical neurons |
KCl stimulated, control shRNA |
Permissive
Robust
|
Mus musculus |
GSE60192
...
|
MA0099.3
...
|
FOS |
cortical neurons |
KCl stimulated, c-Fos shRNA |
Permissive
|
Mus musculus |
GSE60192
...
|
MA0099.3
...
|
FOS |
cortical neurons |
KCl stimulated, control shRNA |
Permissive
Robust
|
Mus musculus |
GSE60192
...
|
MA0099.3
...
|
FOS |
cortical neurons |
KCl stimulated, c-Fos shRNA |
Permissive
|
Mus musculus |
GSE60192
...
|
MA0099.3
...
|
FOS |
bone marrow-derived macrophages |
lipid A 0 min |
Permissive
Robust
|
Mus musculus |
GSE99895
...
|
MA0099.3
...
|
FOS |
bone marrow-derived macrophages |
lipid A 15 min |
Permissive
Robust
|
Mus musculus |
GSE99895
...
|
MA0099.3
...
|
FOS |
bone marrow-derived macrophages |
lipid A 30 min |
Permissive
Robust
|
Mus musculus |
GSE99895
...
|
MA0099.3
...
|
FOS |
bone marrow-derived macrophages |
lipid A 60 min |
Permissive
Robust
|
Mus musculus |
GSE99895
...
|
MA0099.3
...
|
FOS |
bone marrow-derived macrophages |
lipid A 120 min |
Permissive
Robust
|
Mus musculus |
GSE99895
...
|
MA0099.3
...
|
FOS |
THP-1 (acute monocytic leukemia) |
Treatment: untreated, eGFP(EP mRNA) |
Permissive
Robust
|
Homo sapiens |
GSE103477
...
|
MA0099.3
...
|
FOS |
THP-1 (acute monocytic leukemia) |
Treatment: Pam3csk4 treated 4hr, eGFP(EP mRNA) |
Permissive
Robust
|
Homo sapiens |
GSE103477
...
|
MA0099.3
...
|
FOS |
MCF10A-ER-Src |
Genotype: non-transformed |
Permissive
Robust
|
Homo sapiens |
GSE115597
...
|
MA0099.3
...
|
FOS |
MCF10A-ER-Src |
Genotype: transformed |
Permissive
Robust
|
Homo sapiens |
GSE115597
...
|
MA0099.3
...
|
FOS |
primary fibroblasts |
Treatment: starved with 0.5% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J Age: E13.5-E14.5 |
Permissive
Robust
|
Mus musculus |
GSE83295
...
|
MA0099.3
...
|
FOS |
primary fibroblasts |
Treatment: starved with 0.5% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J Age: E13.5-E14.5 |
Permissive
Robust
|
Mus musculus |
GSE83295
...
|
MA0099.3
...
|
FOS |
primary fibroblasts |
Treatment: 90min stimulation with 15% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J Age: E13.5-E14.5 |
Permissive
Robust
|
Mus musculus |
GSE83295
...
|
MA0099.3
...
|
FOS |
primary fibroblasts |
Treatment: 90min stimulation with 15% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J Age: E13.5-E14.5 |
Permissive
Robust
|
Mus musculus |
GSE83295
...
|
MA0099.3
...
|
FOS |
primary fibroblasts |
Treatment: 90min stimulation with 15% serum media Passage: 3 Genotype: Fos -/- ( FOS knockout) Strain:C57BL/6J Age: E13.5-E14.5 |
Permissive
Robust
|
Mus musculus |
GSE83295
...
|
MA0099.3
...
|
FOS |
primary fibroblasts |
Treatment: 90min stimulation with 15% serum media Passage: 3 Genotype: Fos -/- ( FOS knockout) Strain:C57BL/6J Age: E13.5-E14.5 |
Permissive
|
Mus musculus |
GSE83295
...
|
MA0099.3
...
|
FOS |
primary fibroblasts |
Treatment: 90min stimulation with 15% serum media Strain: SPRET/EiJ Genotype: wildtype Age: E13.5-E14.5 |
Permissive
Robust
|
Mus musculus |
GSE83295
...
|
MA0099.3
...
|
FOS |
primary fibroblasts |
Treatment: 90min stimulation with 15% serum media Strain: SPRET/EiJ Genotype: wildtype Age: E13.5-E14.5 |
Permissive
Robust
|
Mus musculus |
GSE83295
...
|
MA0099.3
...
|
FOS |
bone marrow-derived macrophages |
Sex: male; Strain:C57Bl/6EiJ; Treatment: KLA for 1 hr; Source: thioglycollate elicited macrophage cells; |
Permissive
Robust
|
Mus musculus |
GSE111854
...
|
MA0099.3
...
|
FOS |
bone marrow-derived macrophages |
Sex: male; Strain:C57Bl/6EiJ; Treatment: PBS (Veh); Source: thioglycollate elicited macrophage cells; |
Permissive
Robust
|
Mus musculus |
GSE111854
...
|
MA0099.3
...
|
FOS |
bone marrow-derived macrophages |
Sex: male; Strain:Balb/cJ; Treatment: KLA for 1 hr; Source: thioglycollate elicited macrophage cells; |
Permissive
Robust
|
Mus musculus |
GSE111854
...
|
MA0099.3
...
|
FOS |
bone marrow-derived macrophages |
Sex: male; Strain:Balb/cJ; Treatment: PBS (Veh); Source: thioglycollate elicited macrophage cells; |
Permissive
Robust
|
Mus musculus |
GSE111854
...
|
MA0099.3
...
|
FOS |
K562 (myelogenous leukemia) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000DKB
|
MA0476.1
|
FOS |
HUVEC-C (HUVEC, umbilical vein endothelial cells) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000EVU
|
MA0476.1
|
FOS |
K562 (myelogenous leukemia) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000FAI
|
MA0476.1
|
FOS |
IMR90 (lung fibroblasts) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR124AIG
|
MA0099.3
...
|
FOS |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR569XNP
|
MA0099.3
...
|
FOS |
K562 (myelogenous leukemia) |
|
Permissive
Robust
|
Homo sapiens |
GSE19546
...
|
MA0099.3
...
|
FOS |
GM12878 (female B-cells lymphoblastoid cell line) |
|
Permissive
Robust
|
Homo sapiens |
GSE30399
...
|
MA0099.3
...
|
FOS |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
|
Homo sapiens |
GSE26831
...
|
MA0099.3
...
|
FOS |
mast cells |
|
Permissive
Robust
|
Mus musculus |
GSE48085
...
|
MA0099.3
...
|
FOS |
cortical neurons |
|
Permissive
|
Mus musculus |
GSE60192
...
|
MA0099.3
...
|
FOS |
cortical neurons |
|
Permissive
|
Mus musculus |
GSE60192
...
|
MA0099.3
...
|
FOS |
cortical neurons |
|
Permissive
Robust
|
Mus musculus |
GSE60192
...
|
MA0099.3
...
|
FOS |
cortical neurons |
|
Permissive
|
Mus musculus |
GSE60192
...
|
MA0099.3
...
|
FOS |
mesenchymal stem cells |
|
Permissive
Robust
|
Mus musculus |
GSE88986
...
|
MA0099.3
...
|
FOS |
MV-4-11 (Childhood acute monocytic leukemia) |
SHFLT3 |
Permissive
|
Homo sapiens |
GSE64862
|
MA0476.1
|
FOS |
MV-4-11 (Childhood acute monocytic leukemia) |
|
Permissive
Robust
|
Homo sapiens |
GSE64862
|
MA0476.1
|